Innovative Ultrasound Helmet Facilitates Non-Invasive Deep Brain Stimulation
A novel ultrasound helmet enables non-invasive, targeted stimulation of deep brain structures, promising advances in neuroscience research and treatment of neurological disorders without surgery.
Researchers from University College London and the University of Oxford have developed a groundbreaking ultrasound helmet that enables precise stimulation of deep brain regions without the need for surgical intervention. This innovative device opens new doors for both neurological research and the treatment of disorders such as Parkinson's disease by allowing scientists and clinicians to modulate brain activity with unprecedented accuracy. Traditional transcranial ultrasound stimulation (TUS) techniques have struggled to reach deep brain structures with sufficient precision, often affecting broader areas than intended. The new system overcomes these limitations by employing a helmet equipped with 256 focused ultrasound elements that target specific neural circuits, along with a soft plastic face mask that stabilizes the head for accurate targeting.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Women's Hormonal Stress Response Shows Less Reactivity to High-Dose Alcohol, Implicating Tolerance Development
New research reveals that women’s hormonal and autonomic stress responses to high-dose alcohol are less reactive than men’s, potentially impacting alcohol tolerance and disorder risk.
Innovative Shape-Shifting Material Could Revolutionize Medical Implants and Ingestible Devices
A groundbreaking metamaterial developed by Rice University researchers offers dynamic shape-shifting capabilities for safer, more effective implantable and ingestible medical devices, promising to revolutionize their design and functionality.
Revolutionizing Glioblastoma Monitoring Through Repeated Brain Tumor Sampling
New research demonstrates that repeated brain tumor biopsies can reveal treatment responses in glioblastoma patients, even when MRI scans suggest progression, paving the way for personalized therapy strategies.